Karien Bloem

1.1k total citations
31 papers, 716 citations indexed

About

Karien Bloem is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Karien Bloem has authored 31 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Rheumatology. Recurrent topics in Karien Bloem's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Immunotherapy and Immune Responses (8 papers) and Biosimilars and Bioanalytical Methods (8 papers). Karien Bloem is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Immunotherapy and Immune Responses (8 papers) and Biosimilars and Bioanalytical Methods (8 papers). Karien Bloem collaborates with scholars based in Netherlands, United States and Spain. Karien Bloem's co-authors include Theo Rispens, Yvette van Kooyk, Juan J. García‐Vallejo, Gertjan Wolbink, Annick de Vries, Sandra J. van Vliet, Michael T. Nurmohamed, Ana Martínez‐Feito, Borja Hernández‐Breijo and Ilona M. Vuist and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Annals of Neurology.

In The Last Decade

Karien Bloem

31 papers receiving 708 citations

Peers

Karien Bloem
Christophe Lallemand France
Zhao‐Hua Zhou China
Neelima M. Bhat United States
Marcia M. Bieber United States
Altan Ercan United States
Anna M. Davies United Kingdom
Barbara Potempa United States
Nilufer P. Seth United States
L Gemmell United States
Maxime Lecerf France
Christophe Lallemand France
Karien Bloem
Citations per year, relative to Karien Bloem Karien Bloem (= 1×) peers Christophe Lallemand

Countries citing papers authored by Karien Bloem

Since Specialization
Citations

This map shows the geographic impact of Karien Bloem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karien Bloem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karien Bloem more than expected).

Fields of papers citing papers by Karien Bloem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karien Bloem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karien Bloem. The network helps show where Karien Bloem may publish in the future.

Co-authorship network of co-authors of Karien Bloem

This figure shows the co-authorship network connecting the top 25 collaborators of Karien Bloem. A scholar is included among the top collaborators of Karien Bloem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karien Bloem. Karien Bloem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gandhi, Prafull S., Torben Elm, Gerd Schluckebier, et al.. (2024). A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders. Nature Cardiovascular Research. 3(2). 166–185. 10 indexed citations
2.
Bloem, Karien, et al.. (2023). Drug-tolerant detection of anti-drug antibodies in an antigen-binding assay using europium chelate fluorescence. Journal of Immunological Methods. 514. 113436–113436. 4 indexed citations
3.
Keizer, Ron J., Rob ter Heine, Lisa Smits, et al.. (2023). Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot Study. European Journal of Drug Metabolism and Pharmacokinetics. 48(4). 377–385. 5 indexed citations
4.
Bloem, Karien, Birgit I. Lissenberg‐Witte, Eva Strijbis, et al.. (2023). Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 94(6). 487–493. 8 indexed citations
5.
Kempen, Zoé L. E. van, Maurice Steenhuis, Eileen W Stalman, et al.. (2022). Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2 Vaccination Response in Patients with Multiple Sclerosis. Annals of Neurology. 93(1). 103–108. 7 indexed citations
6.
Hart, M., Pleuni Ooijevaar‐de Heer, Karien Bloem, et al.. (2019). Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay. Science Translational Medicine. 11(477). 41 indexed citations
7.
Berends, Sophie E., Karien Bloem, Annick de Vries, et al.. (2019). Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood Samples. Therapeutic Drug Monitoring. 42(2). 289–294. 15 indexed citations
8.
Nurmohamed, Michael T., Irene van der Horst‐Bruinsma, Henk te Velthuis, et al.. (2019). Antidrug antibody detection for adalimumab depends on the type of assay used: an experimental approach to help clinicians interpret diagnostic data.. PubMed. 37(5). 756–761. 2 indexed citations
9.
Horrevorts, Sophie K., Karien Bloem, Pablo Secades, et al.. (2018). Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I. Frontiers in Immunology. 9. 1231–1231. 26 indexed citations
10.
Tsakok, Teresa, Nick Dand, Karien Bloem, et al.. (2018). Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study. Journal of Investigative Dermatology. 139(1). 115–123. 51 indexed citations
11.
Hart, M., Pleuni Ooijevaar‐de Heer, Karien Bloem, et al.. (2018). SAT0189 Dynamics of circulating tnf during adalimumab treatment of rheumatoid arthritis using a novel drug-tolerant tnf assay. Annals of the Rheumatic Diseases. 77. 955–956. 4 indexed citations
12.
Jurado‐Guerrero, Teresa, Chamaida Plasencia‐Rodríguez, Ana Martínez‐Feito, et al.. (2017). Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients. The Open Rheumatology Journal. 11(1). 75–87. 13 indexed citations
13.
Nurmohamed, Michael T., et al.. (2017). OP0025 Antidrug antibodies detection is strongly influenced by the type of assay used. Annals of the Rheumatic Diseases. 76. 61–62. 1 indexed citations
14.
García‐Vallejo, Juan J., Karien Bloem, L.M.J. Knippels, et al.. (2015). The Consequences of Multiple Simultaneous C-Type Lectin–Ligand Interactions: DCIR Alters the Endo-Lysosomal Routing of DC-SIGN. Frontiers in Immunology. 6. 87–87. 23 indexed citations
15.
Bloem, Karien, Astrid van Leeuwen, Michael T. Nurmohamed, et al.. (2015). Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients. Journal of Immunological Methods. 418. 29–38. 58 indexed citations
16.
Bloem, Karien, Juan J. García‐Vallejo, Ilona M. Vuist, et al.. (2013). Interaction of the Capsular Polysaccharide A from Bacteroides fragilis with DC-SIGN on Human Dendritic Cells is Necessary for Its Processing and Presentation to T Cells. Frontiers in Immunology. 4. 103–103. 27 indexed citations
17.
Bloem, Karien, Ilona M. Vuist, L.M.J. Knippels, et al.. (2013). Ligand Binding and Signaling of Dendritic Cell Immunoreceptor (DCIR) Is Modulated by the Glycosylation of the Carbohydrate Recognition Domain. PLoS ONE. 8(6). e66266–e66266. 38 indexed citations
18.
Bloem, Karien, Ilona M. Vuist, Elsenoor J. Klaver, et al.. (2013). DCIR interacts with ligands from both endogenous and pathogenic origin. Immunology Letters. 158(1-2). 33–41. 43 indexed citations
19.
García‐Vallejo, Juan J., Martino Ambrosini, Wilhelmina E. van Riel, et al.. (2012). Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Molecular Immunology. 53(4). 387–397. 89 indexed citations
20.
Strijbis, Karin, Carlo W.T. van Roermund, Guy Hardy, et al.. (2009). Identification and characterization of a complete carnitine biosynthesis pathway in Candida albicans. The FASEB Journal. 23(8). 2349–2359. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christophe Lallemand Breakdown of academic impact, for papers by Zhao‐Hua Zhou Breakdown of academic impact, for papers by Neelima M. Bhat Breakdown of academic impact, for papers by Marcia M. Bieber Breakdown of academic impact, for papers by Altan Ercan Breakdown of academic impact, for papers by Anna M. Davies Breakdown of academic impact, for papers by Barbara Potempa Breakdown of academic impact, for papers by Nilufer P. Seth Breakdown of academic impact, for papers by L Gemmell Breakdown of academic impact, for papers by Maxime Lecerf
Rankless by CCL
2026